Nyxoah S.A. (NYXH) Stock Analysis
NASDAQHealthcareMedical - Specialties
What Nyxoah S.A. does
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Key metrics
ETFs linked to NYXH
Broad-market and Healthcare sector ETFs an investor holding Nyxoah S.A. is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how NYXH fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze NYXH in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Nyxoah S.A.?
- Nyxoah S.A. trades under the ticker NYXH on NASDAQ.
- Which exchange is NYXH listed on?
- NYXH is listed on NASDAQ.
- What sector does Nyxoah S.A. operate in?
- Nyxoah S.A. is classified in the Healthcare sector (Medical - Specialties industry).
- How can PortView help analyze NYXH in a portfolio?
- PortView shows NYXH's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.